Bioscience Briefing
For info about biomedical funding, animal research and other bioscience issues, click here.
Science Policy Announcements
For the latest news from the APS Science Policy click here.
Resource Book Now Available
Click here for more info on The APS Resource Book for the Design of Animal Exercise Protocols.
APS Science Policy Update
August 25, 2006
In this issue:
- NIH issues updated NRSA tuition policy
- New FASEB Breakthroughs in Bioscience Article
- Reaction to this week’s stem cell announcement
Updated NRSA Tuition Policy
Last fall, officials at NIH met with members of the biomedical research community to discuss the problem of rising tuition costs associated with training grants. Tuition increases that outpace inflation have caused the tuition payment policy for National Research Service Awards (NRSAs) to become unsustainable. NIH presented the community with three options: capping tuition payments, providing a fixed allowance per trainee for tuition, or maintaining the current system (with fewer trainees funded each year). On August 18, 2006, NIH formally revised the NRSA tuition policy, announcing that beginning in FY 2007, NRSA awards will cover 60% of tuition expenses up to $16,000 for predoctoral students and $4500 for postdoctoral fellows. In addition to capping tuition costs, funds for trainee health insurance were transferred from the tuition and fees category to training related expenses category. Both the APS and FASEB had expressed concerns about preserving trainee benefits while controlling costs in response to the original request for information.
The revised plan will be reevaluated
based on data collected over the next 2 years and the agency expects
to issue a final policy in July 2010. For more details about the
revised policy, go to:
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-093.html
FASEB Breakthroughs in Bioscience
Breast Cancer, Tamoxifen and beyond: Estrogen and Estrogen Receptors is the latest in FASEB's Breakthroughs in Bioscience series. These materials are developed as part of a broad strategy to advocate for biomedical research funding.
To see the essay online, go to:
http://opa.faseb.org/pdf/Breast_Cancer_Breakthru.pdf
Reaction to stem cell breakthrough
Following this week's article in Nature showing
that stem cell lines have been derived from single cells taken from
early embryos, reaction has been mixed. While some hail this as an
alternative that would avoid ethical and moral issues, others
question whether this method simply raises other ethical dilemmas.
http://www.washingtonpost.com/wp-dyn/content/article/2006/08/23/AR2006082300936.html